Published in J Cancer Res Clin Oncol on April 18, 2010
WWOX: a fragile tumor suppressor. Exp Biol Med (Maywood) (2014) 0.84
Alteration of WWOX in human cancer: a clinical view. Exp Biol Med (Maywood) (2015) 0.80
WWOX, the chromosomal fragile site FRA16D spanning gene: its role in metabolism and contribution to cancer. Exp Biol Med (Maywood) (2015) 0.79
WWOX suppresses KLF5 expression and breast cancer cell growth. Chin J Cancer Res (2014) 0.78
WWOX, large common fragile site genes, and cancer. Exp Biol Med (Maywood) (2015) 0.78
Roles of the WWOX in pathogenesis and endocrine therapy of breast cancer. Exp Biol Med (Maywood) (2014) 0.77
Molecular portraits of human breast tumours. Nature (2000) 94.14
Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A (2003) 34.68
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res (2004) 16.51
Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res (2008) 7.39
Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol (2006) 6.86
Prognostic markers in triple-negative breast cancer. Cancer (2007) 6.28
Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol (2006) 6.07
Basal-like breast cancer: a critical review. J Clin Oncol (2008) 5.64
Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas. Breast Cancer Res (2007) 4.41
WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. Cancer Res (2000) 4.07
WWOX: a candidate tumor suppressor gene involved in multiple tumor types. Proc Natl Acad Sci U S A (2001) 2.79
WWOX, the FRA16D gene, behaves as a suppressor of tumor growth. Cancer Res (2001) 2.12
Centrally necrotizing carcinomas of the breast: a distinct histologic subtype with aggressive clinical behavior. Am J Surg Pathol (2001) 1.96
Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer. Oncogene (2005) 1.90
Genetic alterations of the tumor suppressor gene WWOX in esophageal squamous cell carcinoma. Cancer Res (2002) 1.62
Loss of WWOX expression in gastric carcinoma. Clin Cancer Res (2004) 1.55
The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer. Breast Cancer Res (2002) 1.51
The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma. Cancer (2004) 1.49
The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis. Clin Cancer Res (2004) 1.45
WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer. Cancer Res (2003) 1.42
Frequent loss of WWOX expression in breast cancer: correlation with estrogen receptor status. Breast Cancer Res Treat (2005) 1.33
WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome. BMC Cancer (2005) 1.22
Wwox and Ap2gamma expression levels predict tamoxifen response. Clin Cancer Res (2007) 1.22
Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma. Br J Cancer (2004) 1.22
Osteopontin and p53 expression are associated with tumor progression in a case of synchronous, bilateral, invasive mammary carcinomas. Arch Pathol Lab Med (1997) 1.07
Inhibition of breast cancer cell growth in vitro and in vivo: effect of restoration of Wwox expression. Clin Cancer Res (2007) 1.05
Outcomes in young women with breast cancer of triple-negative phenotype: the prognostic significance of CK19 expression. Int J Radiat Oncol Biol Phys (2007) 0.96
Increased expression of osteopontin in patients with triple-negative breast cancer. Eur J Clin Invest (2008) 0.92
Cyclin D1 expression and early breast cancer recurrence following lumpectomy and radiation. Int J Radiat Oncol Biol Phys (2000) 0.81
Prognostic value of triple-negative phenotype at the time of locally recurrent, conservatively treated breast cancer. Int J Radiat Oncol Biol Phys (2008) 0.81
High-intensity focused ultrasound in patients with late-stage pancreatic carcinoma. Chin Med J (Engl) (2002) 1.16
Lipid-rich carcinoma of the breast. A clinicopathological study of 49 cases. Tumori (2008) 1.07
Functional identification of two novel genes from Pseudomonas sp. strain HZN6 involved in the catabolism of nicotine. Appl Environ Microbiol (2012) 1.04
A sirA-like gene, sirA2, is essential for 3-succinoyl-pyridine metabolism in the newly isolated nicotine-degrading Pseudomonas sp. HZN6 strain. Appl Microbiol Biotechnol (2011) 0.98
FL-CTL assay: fluorolysometric determination of cell-mediated cytotoxicity using green fluorescent protein and red fluorescent protein expressing target cells. J Immunol Methods (2005) 0.97
Elevated expression of phosphorylated c-Jun NH2-terminal kinase in basal-like and "triple-negative" breast cancers. Hum Pathol (2009) 0.84
Akt/PKB interacts with the histone H3 methyltransferase SETDB1 and coordinates to silence gene expression. Mol Cell Biochem (2007) 0.81
Role of ornithine decarboxylase in breast cancer. Acta Biochim Biophys Sin (Shanghai) (2008) 0.80
The mammographic correlations with Basal-like phenotype of invasive breast cancer. Acad Radiol (2009) 0.80
Primary breast carcinoma: association of mammographic calcifications with osteopontin expression. Radiology (2009) 0.79
Down-regulation of GRIM-19 is associated with STAT3 overexpression in breast carcinomas. Hum Pathol (2013) 0.79
Effect of different sites for cryopreserved ovarian tissue implantation in rabbit. Hum Reprod (2006) 0.78
Onsite infectious agents and toxins monitoring in 12 May Sichuan earthquake affected areas. J Environ Monit (2009) 0.78
Successful cryopreservation of whole sheep ovary by using DMSO-free cryoprotectant. J Assist Reprod Genet (2015) 0.78
Cryopreserved ovarian tissues can maintain a long-term function after heterotopic autotransplantation in rat. Reproduction (2009) 0.77
ERBB2-induced inflammation in lung carcinogenesis. Mol Biol Rep (2012) 0.76
Electronic transport calculations for the conductance of Pt-1,4-phenylene diisocyanide-Pt molecular junctions. Nanotechnology (2010) 0.75
Phosphorylated c-Jun NH2-terminal kinase is overexpressed in human papillary thyroid carcinomas and associates with lymph node metastasis. Cancer Lett (2010) 0.75
[Response of cryopreserved ovarian tissue after autologous implantation in mouse stimulated with gonadotrophin]. Zhonghua Fu Chan Ke Za Zhi (2008) 0.75
[Recent applications of solid-phase extraction techniques for analysis of trace residues and contaminants in food]. Se Pu (2011) 0.75
[The double-ring, single-pedicle reduction plasty for gynecomastia]. Zhonghua Zheng Xing Wai Ke Za Zhi (2002) 0.75
[Therapeutic effects of bone marrow transplantation on ovarian injury in mice]. Nan Fang Yi Ke Da Xue Xue Bao (2011) 0.75
Effects of spin-orbit coupling on the conductance of molecules contacted with gold electrodes. J Phys Condens Matter (2009) 0.75
Expression of gene associated with retinoid-interferon-induced mortality-19 in preimplantation embryo of mice. Zhongguo Yi Xue Ke Xue Yuan Xue Bao (2012) 0.75
Developing in vitro reporter gene assays to assess the hormone receptor activities of chemicals frequently detected in drinking water. J Appl Toxicol (2012) 0.75